Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer

International Journal of Cancer

Volumn 123, Issue 10, 2008, Pages 2469-2471

  Smith, Jennifer S ^a   Kumlin, Urban ^b   Nyberg, Fredrik ^c,l   Fortes, Cristina ^d   Zaridze, David ^e   Ahrens, Wolfgang ^f   Bruske Hohlfeld, Irene ^g   Constantinescu, Vali ^h   Ting, Jie ^a   Benhamou, Simone ⁱ   Simonato, Lorenzo ^j   Boman, Jens ^b   Gaborieau, Valerie ^k   Boffetta, Paolo ^k  

^a The University of North Carolina at Chapel Hill   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^e N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^f UNIVERSITY OF BREMEN   (Germany)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

ⁱ INSERM   (France)

^j UNIVERSITY OF PADOVA   (Italy)

^k INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^l ASTRAZENECA   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; BACTERIUM ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; BLOOD SAMPLING; CANCER RISK; CARCINOGENESIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; DISEASE ASSOCIATION; ETIOLOGY; HUMAN; LARGE CELL CARCINOMA; LETTER; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; METHODOLOGY; PRIORITY JOURNAL; RELIABILITY; SAMPLE SIZE; SEROPREVALENCE; SMOKING; BLOOD; CASE CONTROL STUDY; EPIDEMIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LUNG TUMOR; RISK FACTOR;

ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHLAMYDOPHILA PNEUMONIAE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG NEOPLASMS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 53449097157     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23814     Document Type: Letter

References (18)

1. Boffetta P, Trichopoulos D. Cancer of the lung, larynx and pleura. In: Adami HO, Hunter DH, Trichopoulos D, eds. Textbook of cancer epidemiology,2nd edn. New York: Oxford University Press, 2008. 349-77.
2. Antilla T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, Pukkala E, Paavonen J, Saikku P. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 2003;107:681-2.
3. Laurila AL, Antilla T, Laara E, Bloigu A, Virtamo J, Albanes D, Leinonen M, Saikku P. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer (Pred Oncol) 1997;74:31-4.
4. Kocazeybek B. Chronic Chlamydia pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol 2003;52:721-6.
5. Koyi H, Branden E, Gnarpe J, Gnarpe H, Arnholm B, Hillerdal G. Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study. APMIS 1999;107:828-32.
6. Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS 2001;109:572-80.
7. Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2000;9:1263-6.
8. Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, Vayghan TL. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1624-30.
9. Koh WP, Chow VTK, Phoon MC, Ramachandran N, Seow A. Lack of association between chronic Chlamydia pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer 2005;114:502-4.
10. Malats N, Camus-Radon AM, Nyberg F, Ahrens W, Constantinescu V, Mukeria A, Benhamou S, Batura-Gabryel H, Bruske-Hohlfeld I, Simonato L, Menezes A, Lea S, et al. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2000;9:827-33.
11. Mestecky J, McGhee JR. Immunoglobulin A (IgA). Molecular and cellular interaction involved in IgA biosynthesis and immune response. Adv Immunol 1987;2:94-8.
12. von Hertzen L, Leinonen M, Surcel H-M, Karjalainen J, Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with C. pneumoniae. Clin Diagn Lab Immunol 2005;2:454-7.
13. Puhan MA, Steurer J, Bachmann LM, ter Riet G. A randomized trial of ways to describe test accuracy: the effect on physicians' post-test probability estimates. Ann Intern Med 2005;143:184-9.
14. Hermann C, Graf K, Groh A, Straube E, Hartung T. Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 2002;40:1603-9.
15. Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2005;14:773-8.
16. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
17. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, et al.; and the C. pneumonia Workshop participants. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001;33:492-503.
18. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.